Rovin Capital’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,870
Closed -$460K 158
2023
Q4
$460K Sell
5,870
-4,050
-41% -$276K 0.21% 92
2023
Q3
$621K Sell
9,920
-5,630
-36% -$370K 0.29% 48
2023
Q2
$1M Sell
15,550
-510
-3% -$28.7K 0.45% 41
2023
Q1
$851K Sell
16,060
-480
-3% -$23.6K 0.41% 45
2022
Q4
$695K Sell
16,540
-130
-0.8% -$5.44K 0.35% 49
2022
Q3
$610K Buy
16,670
+500
+3% +$22.3K 0.35% 45
2022
Q2
$689K Buy
16,170
+5,380
+50% +$256K 0.46% 38
2022
Q1
$580K Sell
10,790
-260
-2% -$15.1K 0.31% 51
2021
Q4
$795K Buy
11,050
+5,050
+84% +$317K 0.38% 37
2021
Q3
$342K Buy
+6,000
New +$365K 0.23% 48

Other funds holding LRCX

Rovin Capital's LRCX Position: Q1 2024 in Review

Rovin Capital sold out of Lam Research (LRCX) in Q1 2024, closing a stake of 5,870 shares — an estimated $460K sold.

Rovin Capital first reported a position in LRCX in Q3 2021 and held it in 10 quarters. The position peaked at $1M in Q2 2023. 1,730 funds tracked by Wall St. Rank hold LRCX as of Q1 2024.

  • Rovin Capital reported no remaining Lam Research position as of Q1 2024 after selling out during the quarter.
  • Rovin Capital sold 5,870 Lam Research shares in Q1 2024, an estimated $460K.
  • Rovin Capital first reported a position in Lam Research in Q3 2021 and held it in 10 quarters.
  • Rovin Capital's Lam Research position peaked at $1M in Q2 2023.
  • 1,730 funds tracked by Wall St. Rank held Lam Research as of Q1 2024.

Based on Rovin Capital's 13F filing for Q1 2024, filed 22 Apr 2024.